Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats

Neuroscience Letters

Volumn 543, Issue , 2013, Pages 90-94

  Samandari, Razieh ^a   Chizari, Atieh ^b   Hassanpour, Rezvan ^b   Mousavi, Zahra ^b   Haghparast, Abbas ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Acquisition; Conditioned place preference; Diabetes; Extinction; Morphine; Reward

Indexed keywords

INSULIN; INSULIN RECEPTOR; MORPHINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; INSULIN BLOOD LEVEL; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; STREPTOZOCIN DIABETES;

ANIMALS; CONDITIONING (PSYCHOLOGY); DIABETES MELLITUS, EXPERIMENTAL; MALE; MORPHINE; RATS; RATS, WISTAR; REWARD; STREPTOZOCIN;

EID: 84877142508     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.024     Document Type: Article

References (36)

1. Azizi P., Haghparast A., Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav. Brain Res. 2009, 197:119-124.
2. Baluchnejadmojarad T., Roghani M. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav. Brain Res. 2011, 224:305-310.
3. Batchelor M., Schenk J.O. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 1998, 18:10304-10309.
4. Breese G.R., Chu K., Dayas C.V., Funk D., Knapp D.J., Koob G.F., Le D.A., O'Dell L.E., Overstreet D.H., Roberts A.J., Sinha R., Valdez G.R., Weiss F. Stress enhancement of craving during sobriety: a risk for relapse. Alcoholism, Clin. Exp. Res. 2005, 29:185-195.
5. Bruijnzeel A.W., Corrie L.W., Rogers J.A., Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav. Brain Res. 2011, 219:254-264.
6. Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., Galli A. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 2002, 81:859-869.
7. Cruz F.C., Leao R.M., Marin M.T., Planeta C.S. Stress-induced reinstatement of amphetamine-conditioned place preference and changes in tyrosine hydroxylase in the nucleus accumbens in adolescent rats. Pharmacol. Biochem. Behav. 2010, 96:160-165.
8. Davis J.F., Choi D.L., Benoit S.C. Insulin, leptin and reward. Trends Endocrinol. Metab. 2010, 21:68-74.
9. Daws L.C., Avison M.J., Robertson S.D., Niswender K.D., Galli A., Saunders C. Insulin signaling and addiction. Neuropharmacology 2011, 61:1123-1128.
10. Doolen S., Zahniser N.R. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J. Pharmacol. Exp. Ther. 2001, 296:931-938.
11. Eccles M.P., Hrisos S., Francis J.J., Stamp E., Johnston M., Hawthorne G., Steen N., Grimshaw J.M., Elovainio M., Presseau J., Hunter M. Instrument development, data collection, and characteristics of practices, staff, and measures in the Improving Quality of Care in Diabetes (iQuaD) Study. Implementation Sci. 2011, 6:61.
12. Figlewicz D.P. Insulin food intake, and reward. Semin. Clin. Neuropsychiatry 2003, 8:82-93.
13. Figlewicz D.P., Bennett J., Evans S.B., Kaiyala K., Sipols A.J., Benoit S.C. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behav. Neurosci. 2004, 118:479-487.
14. Figlewicz D.P., Bennett J.L., Aliakbari S., Zavosh A., Sipols A.J. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2008, 295:R388-R394.
15. Fulton S., Richard D., Woodside B., Shizgal P. Food restriction and leptin impact brain reward circuitry in lean and obese Zucker rats. Behav. Brain Res. 2004, 155:319-329.
16. Galici R., Galli A., Jones D.J., Sanchez T.A., Saunders C., Frazer A., Gould G.G., Lin R.Z., France C.P. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 2003, 77:132-140.
17. Garcia B., Wei Y., Moron J., Lin R., Javitch J., Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 2005, 68:102-109.
18. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 1993, 14:43-49.
19. Goeders N.E. The impact of stress on addiction. Eur. Neuropsychopharmacol. 2003, 13:435-441.
20. Gordon H.W. Early environmental stress and biological vulnerability to drug abuse. Psychoneuroendocrinology 2002, 27:115-126.
21. Ho N., Balu D.T., Hilario M.R., Blendy J.A., Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol. Behav. 2012, 105:702-708.
22. Kahlig K.M., Galli A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 2003, 479:153-158.
23. Moaddab M., Haghparast A., Hassanpour-Ezatti M. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav. Brain Res. 2009, 198:466-471.
24. Nasri S., Roghani M., Baluchnejadmojarad T., Rabani T., Balvardi M. Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats. Pathophysiology 2011, 18:273-278.
25. Owens W.A., Sevak R.J., Galici R., Chang X., Javors M.A., Galli A., France C.P., Daws L.C. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 2005, 94:1402-1410.
26. Patterson T.A., Brot M.D., Zavosh A., Schenk J.O., Szot P., Figlewicz D.P. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 1998, 68:11-20.
27. Plum L., Schubert M., Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 2005, 16:59-65.
28. Schoffelmeer A.N., Drukarch B., De Vries T.J., Hogenboom F., Schetters D., Pattij T. Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J. Neurosci. 2011, 31:1284-1291.
29. Sedaghat R., Roghani M., Ahmadi M., Ahmadi F. Antihyperglycemic and antihyperlipidemic effect of Rumex patientia seed preparation in streptozotocin-diabetic rats. Pathophysiology 2011, 18:111-115.
30. Shaham Y., Stewart J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 1995, 119:334-341.
31. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology 2001, 158:343-359.
32. Stranahan A.M., Lee K., Pistell P.J., Nelson C.M., Readal N., Miller M.G., Spangler E.L., Ingram D.K., Mattson M.P. Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels. Neurobiol. Learn. Mem. 2008, 90:479-483.
33. Taslimi Z., Arezoomandan R., Omranifard A., Ghalandari-Shamami M., Riahi E., Vafaei A.A., Rashidy-Pour A., Haghparast A. Orexin A in the ventral tegmental area induces conditioned place preference in a dose-dependent manner: involvement of D1/D2 receptors in the nucleus accumbens. Peptides 2012, 37:225-232.
34. Uhart M., Wand G.S. Stress, alcohol and drug interaction: an update of human research. Addict. Biol. 2009, 14:43-64.
35. Vaughn L.K., Mantsch J.R., Vranjkovic O., Stroh G., Lacourt M., Kreutter M., Hillard C.J. Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 2012, 204:117-124.
36. Williams J.M., Owens W.A., Turner G.H., Saunders C., Dipace C., Blakely R.D., France C.P., Gore J.C., Daws L.C., Avison M.J., Galli A. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol. 2007, 5:e274.